Refine Search
(295)
(503)
(521)
(649)

Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2018’, provides an overview of the Amyotrophic Lateral Sclerosis pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Ulcerative Colitis - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H1 2018’, provides an overview of the Ulcerative Colitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ulcerati...

Klebsiella pneumoniae Infections - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Klebsiella pneumoniae Infections - Pipeline Review, H1 2018’, provides an overview of the Klebsiella pneumoniae Infections pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2018’, provides an overview of the Chagas Disease (American Trypanosomiasis) pipeline landscape.

The report provides comprehensive information on t...

Hepatitis D - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hepatitis D - Pipeline Review, H1 2018’, provides an overview of the Hepatitis D pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hepatitis D, complete ...

Yellow Fever - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Yellow Fever - Pipeline Review, H1 2018’, provides an overview of the Yellow Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Yellow Fever, comple...

Chikungunya Fever - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chikungunya Fever - Pipeline Review, H1 2018’, provides an overview of the Chikungunya Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chikunguny...

Neisseria meningitidis Infections - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neisseria meningitidis Infections - Pipeline Review, H1 2018’, provides an overview of the Neisseria meningitidis Infections pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Haemophilus influenzae Type B Infections - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Haemophilus influenzae Type B Infections - Pipeline Review, H1 2018’, provides an overview of the Haemophilus influenzae Type B Infections pipeline landscape.

The report provides comprehensive information on the...

Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2018’, provides an overview of the Thrombotic Thrombocytopenic Purpura pipeline landscape.

The report provides comprehensive information on the therapeut...

Rotavirus Infections - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rotavirus Infections - Pipeline Review, H1 2018’, provides an overview of the Rotavirus Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rota...

Inclusion Body Myositis (IBM) - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Inclusion Body Myositis (IBM) - Pipeline Review, H1 2018’, provides an overview of the Inclusion Body Myositis (IBM) pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Pheochromocytoma - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pheochromocytoma - Pipeline Review, H1 2018’, provides an overview of the Pheochromocytoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pheochromocy...

Premature Ejaculation - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Premature Ejaculation - Pipeline Review, H1 2018’, provides an overview of the Premature Ejaculation pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pr...

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2018’, provides an overview of the Adrenocortical Carcinoma (Adrenal Cortex Cancer) pipeline landscape.

The report provides comprehensive in...